Net profit of Marksans Pharma reported to Rs 37.01 crore in the quarter ended March 2013 as against net loss of Rs 118.04 crore during the previous quarter ended March 2012. Sales rose 45.19% to Rs 58.67 crore in the quarter ended March 2013 as against Rs 40.41 crore during the previous quarter ended March 2012.
For the Audited full year,net profit reported to Rs 39.58 crore in the year ended March 2013 as against net loss of Rs 181.07 crore during the previous year ended March 2012. Sales rose 24.39% to Rs 192.30 crore in the year ended March 2013 as against Rs 154.59 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales58.6740.41 45 192.30154.59 24 OPM %54.87-288.52 119 25.19-99.00 125 PBDT29.21-120.00 LP 38.30-164.93 LP PBT27.03-119.88 LP 29.60-182.91 LP NP37.01-118.04 LP 39.58-181.07 LP
Powered by Capital Market - Live News
